---
url: https://www.absci.com/about-us/team/
title: "Team | Absci"
clipped: 2026-01-24 22:02
source: browser-history
---

# Team | Absci

> Source: [https://www.absci.com/about-us/team/](https://www.absci.com/about-us/team/)

# Meet Our Team

###### Leadership Team

![team_Sean_McClain](https://www.absci.com/wp-content/uploads/2025/03/team_Sean_McClain.jpg?_t=1741723186 "team_Sean_McClain")

### Sean McClain

Founder, CEO & Director

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![team_Sean_McClain](https://www.absci.com/wp-content/uploads/2025/03/team_Sean_McClain.jpg "team_Sean_McClain")

### Did you know?:

Sean loves chess and perfecting his weekend BBQ with the dream of opening a pop-up restaurant with his favorite chef, Gregory Gourdet.

## Sean McClain

### Founder, CEO & Director

Sean McClain is the Founder and CEO of Absci, a leading generative AI Drug Creation company with a mission to create better biologics for patients, faster.

Sean embodies entrepreneurial spirit, having built Absci from basement lab to a publicly traded company and continuing to strive towards his vision to create therapeutics at the click of a button. Under his leadership, Absci scaled to over 200 employees, raised over $530M in capital, established a growing number of industry-leading partnerships, developed an internal portfolio of AI discovered drug assets, and built an Integrated Drug Creation Platform that merges bleeding-edge generative AI models with proprietary high-throughput wet-lab data.

Sean is a graduate of the University of Arizona and has been the recipient of numerous recognitions for his entrepreneurship and innovation. He serves as a board member for the Oregon Translational Research and Development Institute, and Life Science Washington.

![Zach_Jonasson-img](https://www.absci.com/wp-content/uploads/2025/02/Zach_Jonasson-img.jpg?_t=1762967442 "Zach_Jonasson-img")

### Zach Jonasson, PhD

Chief Financial Officer & Chief Business Officer

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Zach_Jonasson-img](https://www.absci.com/wp-content/uploads/2025/02/Zach_Jonasson-img.jpg?_t=1762970874 "Zach_Jonasson-img")

### Did you know?:

As a Sackler Scholar at Harvard, Zach studied the neurobiology underlying learning and memory.

## Zach Jonasson, PhD

### Chief Financial Officer & Chief Business Officer

Zach Jonasson, PhD is the CFO and CBO of Absci. Prior to these roles, Dr. Jonasson served as an independent member of Absci's board of directors and as chairman of the board from April 2016 to October 2020.

Previously, Dr. Jonasson was a co-founder and Managing General Partner of two venture capital firms, Phoenix Venture Partners LLC (PVP) and Convergent Ventures, where he led both firm's venture capital investment strategies in the biotechnology sector. In those roles, he led investments in companies such as Absci, Valence Therapeutics (acquired by Recursion Pharmaceuticals), Sentinel Monitoring Systems (acquired by SUEZ), Totient (acquired by Absci), and ProFluent Bio, and he established fund investment partnerships with multinational corporations such as Pfizer, Corning, and L'Oreal. Earlier in his career, Dr. Jonasson was a General Partner at Seaflower Ventures, where he led multiple investments in companies including Serenex (acquired by Pfizer) and Metaworks (acquired by United Biosource Corporation) and was a co-founder of several companies, including Risk Capital Management and Corp Enhancement.

Dr Jonasson earned his PhD in Behavioral Neuroscience from Harvard University, where he was a Sackler Scholar, an AM in Statistics from Harvard University, and a BS in Economics from the Honors Program at Georgetown University.

![Andreas-Busch@2x.jpg](https://www.absci.com/wp-content/uploads/2025/03/Andreas-Busch@2x.jpg.jpg?_t=1741723186 "Andreas-Busch@2x.jpg")

### Andreas Busch, PhD

Chief Innovation Officer

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Andreas-Busch@2x.jpg](https://www.absci.com/wp-content/uploads/2025/03/Andreas-Busch@2x.jpg.jpg?_t=1741725783 "Andreas-Busch@2x.jpg")

### Did you know?:

Andreas loves (real) football and even played in the minor league in Germany, enjoys riding his motorbike thru Alps and, of course, playing with his beloved dog Zorro (Number 1 in Penelope's succession list).

## Andreas Busch, PhD

### Chief Innovation Officer

Andreas Busch, PhD, Chief Innovation Officer is responsible for leading R&D, technical operations, and driving both Absci's internal and partner programs. Dr. Busch brings substantial R&D expertise to Absci's leadership team as a world-renowned leader in drug discovery and has led R&D efforts for some of the globe's top pharma companies including Sanofi, Bayer, and Shire. His leadership has resulted in over 10 commercial drugs starting from bench to FDA approval with several more in late stage clinical development. He holds the title of Extraordinary Professor of Pharmacology at the Johann Wolfgang Goethe-University in Frankfurt, Germany, where he also received his PhD in Pharmacology.

![Shelby-Walker@2x](https://www.absci.com/wp-content/uploads/2025/03/Shelby-Walker@2x.jpg?_t=1741723186 "Shelby-Walker@2x")

### Shelby Walker, JD

Chief Legal Officer

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Shelby-Walker@2x](https://www.absci.com/wp-content/uploads/2025/03/Shelby-Walker@2x.jpg?_t=1741725955 "Shelby-Walker@2x")

### Did you know?:

Shelby and her husband ride Icelandic horses and enjoy endurance riding both in the US and Iceland.

## Shelby Walker, JD

### Chief Legal Officer

Shelby Walker, JD, Chief Legal Officer, leads Absci's legal team and oversees the company's legal affairs, business transactions, intellectual property, risk management, and compliance. Shelby joined Absci from Korro Bio, Inc. where she served as General Counsel & Corporate Secretary. Previously, she held senior leadership roles as Senior Vice President, Intellectual Property at CRISPR Therapeutics and General Counsel at Ginkgo Bioworks.

Shelby holds a JD and LLM from UNH Franklin Pierce School of Law, dual MS degrees in Bioscience Regulatory Affairs and Biotechnology from Johns Hopkins University, and a BS degree in Biotechnology from Worcester Polytechnic Institute.

![Karin-Wierinck@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Karin-Wierinck@2x")

### Karin Wierinck

Chief People Officer

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Karin-Wierinck@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Karin-Wierinck@2x")

### Did you know?:

Karin's joy is spending time with family and friends, preferably by the sea or in the mountains. She loves food and travel, and her Pomeranian, Bono, is a regular travel companion. Karin is thrilled that Bono can come with her to work and collaborate with other Unlimiter canines!

## Karin Wierinck

### Chief People Officer

Karin Wierinck, Chief People Officer, brings deep experience from her leadership roles at top biotech and pharma companies such as Takeda, Novo Nordisk, and Pfizer. Karin has partnered with diverse executive leadership teams to create business value within dynamic, high-growth environments, all while ensuring strong HR service delivery. Her experience working in the US, Switzerland, and throughout Europe will help Absci develop its global talent base. Karin is passionate about building positive cultures based on trust and transparency. She holds Masters degrees in German Philology and Plurilingual Business Communication from Ghent University, and a Masters Degree in HR Leadership from Rutgers University.

![Amir](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Amir")

### Amir Shanehsazzadeh

Chief AI Officer

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Amir](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Amir")

## Amir Shanehsazzadeh

### Chief AI Officer

Amir Shanehsazzadeh, Chief AI Officer, leads Absci's AI Biologics Discovery and Engineering team, overseeing the development, experimental validation, and deployment of Absci's AI Platform for *de novo* antibody design and optimization. Amir holds degrees in Mathematics and Statistics from Harvard University.

![Christine-Lemke@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Christine-Lemke@2x")

### Christine Lemke, PhD, DVM, MBA

SVP, Portfolio and Growth Strategy

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Christine-Lemke@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Christine-Lemke@2x")

### Did you know?

In the nineties, Christine bred warmblood sport horses from her home state, Schleswig-Holstein called "Holsteiner". She loves eating out with friends, hiking in the Alps with her partner Joerg and gardening in her second home in France.

## Christine Lemke, PhD, DVM, MBA

### SVP, Portfolio and Growth Strategy

Christine Lemke, DVM, MBA, Senior Vice President, Portfolio and Growth Strategy, is responsible for implementing and driving a rigorous strategic planning and portfolio management process. As a seasoned international executive, she brings substantial corporate development and operations expertise to Absci. For global bio-pharmaceutical companies, including Bayer, Shire and Takeda, Christine delivered multiple global, cross-functional strategic projects sponsored by executive board members. She holds a DVM from FU Berlin, a PhD from School of Veterinary Medicine Hannover as well as an MBA from University of Denver and is based in Zurich, Switzerland.

![Todd-Bedrick@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Todd-Bedrick@2x")

### Todd Bedrick, CPA

SVP, Chief Accounting Officer

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Todd-Bedrick@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Todd-Bedrick@2x")

### Did you know?:

Todd loves iced coffee, traveling to new places, and paddleboarding lakes and rivers with his wife and two children. He is also a long-time Portland Trailblazers fan!

## Todd Bedrick, CPA

### SVP, Chief Accounting Officer

Todd Bedrick, Chief Accounting Officer, oversees the accounting and reporting, corporate tax, financial planning and analysis, acquisition integration and has managed multiple company-wide system implementations. Todd played a crucial role through the company's IPO. His prior experience includes being a senior audit manager at Ernst & Young and the Director of Technical Accounting at The Greenbrier Companies. Todd earned his BSBA in Accounting from the University of Arizona - Eller College of Management, he also holds an MS in Financial Analysis, received from Portland State University - School of Business.

![Wen-Sha@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Wen-Sha@2x")

### Wen Sha

Chief of Staff

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Wen-Sha@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Wen-Sha@2x")

### Did you know?:

Outside of work Wen enjoys exploring new foods, collecting vinyl records, and spending time in the Canadian Rockies where he is originally from.

## Wen Sha

### Chief of Staff

Wen Sha is VP, Strategy & Business Operations, and Chief of Staff to Absci’s Founder & CEO, partnering with the executive team to drive priority internal and external initiatives. He also leads the marketing & communications, business operations, alliance management, and growth strategy teams at Absci. Prior to joining Absci, Wen led Business Operations & Portfolio Management at Seagen. He has worked across large biopharma, high-growth startups, and consulting, with responsibilities spanning corporate strategy, R&D portfolio management, and Chief of Staff roles. Wen holds degrees in Economics and in Management from the University of Alberta and Yale University, respectively.

![Amer_Denis_Akkad](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20429%20581'%3E%3C/svg%3E "Amer_Denis_Akkad")

### Amer Denis Akkad PhD

VP, Research

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Amer_Denis_Akkad](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20429%20581'%3E%3C/svg%3E "Amer_Denis_Akkad")

### Did you know?

Amer enjoys exploring new cities and cultures with his wife, where they try new try new hiking routes and sample the local cuisine

## Amer Denis Akkad

### VP, Research

Amer-Denis, VP of Research, leads translational research and preclinical toxicology for de novo antibody drug candidates developed by Absci's proprietary AI models. He is also responsible for ensuring profile alignment and executing the early clinical development strategy. Prior to joining Absci, Amer led drug discovery efforts at Bayer, overseeing projects from early target identification to preclinical candidate selection. Amer also spent four years at the Broad Institute of MIT and Harvard, where he helped establish and lead the Precision Cardiology Laboratory initiative. He holds a Ph.D. in Neuroscience from the International Graduate School of Neuroscience in Germany and has qualifications in clinical laboratory genetics.

![Alexander@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Alexander@2x")

### Alexander Khan, CPA

VP, Finance & Investor Relations

![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2039%2039'%3E%3C/svg%3E) 

![Alexander@2x](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20638%20864'%3E%3C/svg%3E "Alexander@2x")

### Did you know?

Alex enjoys biking, running, cooking, and music and is a longstanding New York Mets fan.

## Alexander Khan, CPA

### VP, Finance & Investor Relations

Alex Khan, Vice President, Finance & Head of Investor Relations interfaces with existing and prospective investors as well as sell side equity research analysts, and partners with the Executive Leadership Team on financial and investor-facing strategy and operations. His prior experience before joining Absci includes healthcare investor relations and advisory, equity research, and pub

[... truncated ...]